Project Grant R01AR083168

Award Date 7/30/24
Completion Date 6/30/28
Dollars Obligated $1.2M
Federal Grant Program
93.846
Assistance Type
Project Grant
Place of Performance
Providence, RI 02903, USA
Similar Awards
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research, provides $488,782 to conduct research on the use of neuromuscular electrical stimulation (NMES) to address quadriceps weakness and atrophy following anterior cruciate ligament (ACL) injury and reconstruction. The overarching objective is to establish the mechanistic basis for how NMES can mitigate the...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will provide $139,050 in funding to the University of Utah over a five-year period from July 2024 to June 2029. The purpose of this award is to support the research of Dr. Stephan Bodkin, an assistant professor at the University of Utah, in investigating the influence of anterior cruciate...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $549,437 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The grant, effective September 1, 2024 through June 30, 2029, aims to develop a novel therapy that leverages the Hedgehog signaling pathway to improve tendon-to-bone...
This federal Project Grant award from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) provides $520,154 to Arcadia University to conduct research on improving quadriceps muscle function and reducing the risk of post-traumatic osteoarthritis in individuals recovering from anterior cruciate ligament (ACL) reconstruction surgery. The key objectives of the project are to: 1) Determine if non-invasive brain...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research federal grant program (CFDA 93.846), provides $147,236 to the University of Pittsburgh to quantify the mechanical effects of knee bracing and develop computational models to predict its ability to prevent ligamentous injuries such as medial collateral ligament (MCL) and anterior cruciate ligament (ACL) injuries. The...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $388,960 Project Grant (CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research) to the Medstar Health Research Institute Inc. to evaluate the use of machine learning algorithms to analyze accelerometry data and gain insights into functional recovery of the upper extremity following distal radius fracture repair. The project aims to train algorithms to differentiate functional versus...
This federal Project Grant award, valued at $616,256 and awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under CFDA Program 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research, is focused on developing and validating a regenerative rehabilitation (Regen-Rehab) therapy for the treatment of volumetric muscle loss (VML) defects. The primary goals of the project are to develop an "intelligent" biorobot, a piezoelectric construct...
This $468,769 federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under CFDA Program 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research supports preclinical research to identify effective physical therapy and biological intervention strategies to reduce post-traumatic joint contracture (PTJC) following joint injury, particularly in the elbow. The key objectives are to: 1) Determine the optimal parameters of active...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $704,514 Project Grant (CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research) to the University of Texas Health Science Center at Houston to conduct a multi-center, longitudinal study on acromioclavicular (AC) joint reconstruction techniques. The study aims to compare shoulder mechanics and soft tissue health outcomes for three surgical approaches: 1) coracoclavicular reconstruction alone...
This $556,160 Project Grant awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (CFDA 93.846) aims to examine the efficacy of a rehabilitation approach called Rehabilitation with Exercise and Psychological Support (REPS) for patients who have undergone ACL reconstruction surgery. The REPS intervention integrates standard exercise rehabilitation with psychological support, including clinician training, patient education videos, and techniques like...

This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $1,197,166 to Rhode Island Hospital to evaluate a neuromuscular mechanism that may explain differences in functional outcomes between two anterior cruciate ligament (ACL) surgery procedures. The overarching objective is to leverage patients enrolled in the BEAR-MOON clinical trial to compare neuromuscular activity patterns and joint motion between the Bridge-Enhanced ACL Restoration (BEAR) procedure, which preserves the ACL neural structures, and standard ACL reconstruction surgery, which severs these structures. The grant supports an ancillary study that will apply machine learning to classify neuromuscular activity, compare knee joint motion during landing, and determine the relationship between neuromuscular patterns and joint motion abnormalities. The University of Texas Health Science Center at Houston received a $263,058 sub-award to collaborate on this research.

Generated 7/1/25, 4:45 AM